Seborrheic Keratosis (SK)

DBCOND0116301Skin and Subcutaneous Tissue Diseases

Seborrheic Keratosis (SK) is the indication for 1 drug in DrugBank. It is covered by 1 curated, structured indication.

Also known as
Keratosis, Seborrheic · Seborrhoeic keratosis · Seborrheic Keratosis · Seborrheic Keratoses
Classified under
Indicated drugs

Resolves to

Vocabularies
MeSHM0026535ICD-10L57.0SNOMED CT103672009MedDRA10000614UMLSC0011645

What you can answer from here — as of October 22, 2026

1Indicated drugWith each drug's targets and mechanism
Listed above
1Structured indicationPopulation, line of therapy, route and combination as fields, not prose
Sign in
13Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1Drug reporting it as an adverse effectWith incidence where the label states it
Sign in

Which approved drugs for Seborrheic Keratosis (SK) share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In